Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Men with Frontal fibrosing alopecia typically lose hair on the front scalp and sometimes on sideburns and upper lip, with treatments showing varied success.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

A woman's hair loss was misdiagnosed as alopecia areata but was actually lichen planopilaris, needing immediate and ongoing treatment.

A married couple both developed a rare type of hair loss, possibly due to shared environmental factors.

Wearing a wig caused a skin condition to develop in a woman with hair loss.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

New LPP subtype affects vellus hairs, mimics AGA, and needs biopsy for diagnosis.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Isotretinoin was not effective in treating facial lichen planopilaris.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

A man with Isaac's syndrome affecting only one side of his body improved after immune system-targeted treatment.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Hair loss on the lower legs is common in middle-aged men, usually harmless, and doesn't need treatment.